# Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors

> **NCT03792724** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 32 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Urelumab + Nivolumab

## Key facts

- **NCT ID:** NCT03792724
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-30
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2019-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792724, "Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03792724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*